发明名称 |
Angiopoietin derived peptides |
摘要 |
Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them. |
申请公布号 |
US9255132(B2) |
申请公布日期 |
2016.02.09 |
申请号 |
US201313920103 |
申请日期 |
2013.06.18 |
申请人 |
Compugen Ltd. |
发明人 |
Kliger Yossef;Borukhov Itamar;Levy Ofer;Tiran Zohar;Wool Assaf;Schreiber Ehud;Amir Anat;Levine Zurit;Toporik Amir |
分类号 |
C07K9/00;C07K14/515;A61K38/14;A61K38/18;A61K45/06;A61K47/48 |
主分类号 |
C07K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated peptide consisting of an amino acid sequence selected from the group consisting of:
an amino acid sequence as set forth in any one of SEQ ID NOs: 7-9, or a homolog or a derivative thereof, wherein said peptide has antiangiogenic activity, and wherein said peptide having an amino acid sequence as set forth in SEQ ID NO: 7, or the homolog or derivative thereof has at most 56 amino acids, wherein said peptide having an amino acid sequence as set forth in SEQ ID NO: 8, or the homolog or derivative thereof has at most 43 amino acids and wherein said peptide having an amino acid sequence as set forth in SEQ ID NO: 9, or the homolog or derivative thereof has at most 38 amino acids and wherein said homolog or derivative differs from said amino acid sequence by conservative amino acid substitutions. |
地址 |
Tel-Aviv IL |